Maintaining R&D funding for neglected diseases is "challenging", warn DNDi and MSF
This article was originally published in Scrip
Executive Summary
Maintaining sustainable funding for neglected disease R&D is a "tremendous challenge", the Drugs for Neglected Diseases initiative (DNDi) and Médecins Sans Frontières (MSF) have admitted.